An epidemiological study of the relationship between dioxin (125304) exposure and soft tissue sarcoma was conducted in chemical workers. Employment records, medical and pathological reports, tissue specimens, and death certificates were obtained for seven workers. The potential for exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (1746016), 2,4,5-trichlorophenoxyacetic-acid (93765) (TPA), or trichlorophenol (25167822) (TCP) was evaluated by an examination of death certificates for six deceased persons. Medical records from hospitals and employers were obtained for evaluating the prevalence of soft tissue sarcoma. The tissue specimens were examined in two independent reviews by pathologists with expertise in the area of soft tissue sarcoma. All seven individuals had received a diagnoses of soft tissue sarcomas by their original pathologists; five of the cases were diagnosed as soft tissue sarcoma by each of the two reviewers. The original pathologists and two reviewers all agreed that five individuals had soft tissue sarcomas whereas they agreed on the histological sub type in only two individuals. Of the six deceased cases, four had notations of soft tissue sarcoma on their death certificates; all six deceased individuals and the surviving patient had hospital diagnoses of soft tissue sarcoma. Company medical records for the seven individuals indicated that three cases had records of diagnosed chloracne. Three cases were production workers assigned to the TCP or TPA department. The authors suggest that the use of death certificates alone is inadequate for the evaluation of soft tissue sarcoma outcome.
Links with this icon indicate that you are leaving the CDC website.
The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
You will be subject to the destination website's privacy policy when you follow the link.
CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website.
For more information on CDC's web notification policies, see Website Disclaimers.
CDC.gov Privacy Settings
We take your privacy seriously. You can review and change the way we collect information below.
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
Cookies used to make website functionality more relevant to you. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests.
Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data.
Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. These cookies may also be used for advertising purposes by these third parties.
Thank you for taking the time to confirm your preferences. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page.